does ghk-cu affect growth hormone or igf-1 Targeting GH and in Management of Obesity Mechanisms of Disease: metabolic effects
Description
Moein's level of experties

Here is what the research tells us about its mechanisms
Each capsule delivers a precise 500 mcg total of the synergistic BPC-157 and TB-500 combination in a convenient, stable oral capsule form.Key Research Compound Highlights BPC-157 (Body Protection Compound-157): A synthetic pentadecapeptide derived from human gastric juice, widely studied in preclinical models for its cytoprotective, angiogenic, and anti-inflammatory properties

What makes 5-Amino-1MQ interesting is its ability to block NNMT, an enzyme that rises in obesity and aging
